glp-1 weight loss oral solution how to use A New Option in Management A new once-daily GLP-1, orforglipron (Foundayo™) was FDA approved on April 1, 2026 ATTAIN-1 Trial: ~12.4% average weight (~27 lbs) and Improved cholesterol + 3 Takeaways from the Landmark
Description
a multi-disciplinary expert consensus
Get the full breakdown on costs, treatment, support, and how it compares to other GLP-1 clinics.
What Foods to Avoid While Taking Semaglutide GLP-1?
Coverage of GLP-1 weight-loss drugs is growing among the largest employers (5000+ workers), now at 43%
Slower digestion from GLP-1 medications can cause constipation
